导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.70% | 640/1050 |
| 近一周 | -1.31% | 177/1104 |
| 近一月 | 0.17% | 79/1102 |
| 近一季 | -0.69% | 276/1092 |
| 近半年 | -8.65% | 727/1070 |
| 近一年 | 0.20% | 577/1018 |
| 近两年 | 21.15% | 767/926 |
| 近三年 | 11.59% | 581/834 |
| 成立以来 | 204.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.00% 338/1070 |
-11.75% 952/1101 |
- - |
- - |
| 2025 | 5.19% 886/1065 |
-1.81% 901/1014 |
1.03% 611/1038 |
1.72% 977/1050 |
4.26% 162/1065 |
| 2024 | 15.42% 162/1011 |
7.52% 55/960 |
1.55% 213/983 |
7.91% 777/991 |
-2.04% 451/1011 |
| 2023 | 5.62% 43/952 |
7.36% 202/880 |
1.13% 126/895 |
2.46% 30/915 |
-5.05% 511/952 |
| 2022 | -8.68% 73/867 |
-2.81% 14/773 |
-1.03% 718/806 |
-5.39% 71/845 |
0.35% 431/867 |
| 2021 | 22.42% 141/740 |
5.44% 47/580 |
5.29% 462/659 |
10.74% 55/704 |
-0.42% 455/740 |
| 2020 | 27.21% 359/554 |
-7.83% 351/419 |
7.78% 408/466 |
17.34% 93/517 |
9.12% 375/554 |
| 2019 | 27.68% 301/410 |
23.68% 802/1149 |
-2.81% 573/1231 |
-2.19% 362/390 |
8.59% 214/410 |
| 2018 | -17.56% 44/349 |
- - |
- - |
- - |
-7.59% 132/1080 |
| 2017 | 14.88% 108/285 |
- - |
- - |
- - |
- - |
| 2016 | -4.32% 41/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 前海开源股息率100强股票A VS. 东吴新产业精选股票A(580008) |